Sacha , Tomasz. 2014. “Deep Molecular Response (MR4.5) As a Target of Therapy With Tyrosine Kinase Inhibitors. MR4.5 – Goal of CML Treatment”. OncoReview 4 (1(13), 26-32. https://journalsmededu.pl/index.php/OncoReview/article/view/356.